Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis

NCT02087904 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02087904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02087904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Completed
Start date
June 4, 2014
Completion date
December 13, 2016
Enrollment
350 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis, medial compartment knee osteoarthritis